Vasculitis
- KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment
- KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the Lines
- ANCA-associated GN: the Known and the Unknowns with Dr Andreas Kronbichler
- Current issues in ANCA associated vasculitis
- Anca Vasculitis Columbia
- Michael Walsh, MD, PhD – Plasma exchange and glucocorticoids for ANCA-associated vasculitis
- Management of ANCA vasculitis with Kidney involvement
- Columbia Medicine CME – Kidney disease in anca vasculitis
- Kdigo 2024 Clinical Practice Guideline For The Management Of Antineutrophil Cytoplasmic Antibody (Anca)–associated Vasculitis.
- Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis ; Jurgen Floege et.al. Kidney International (2024).
- Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of granulomatosis with polyangiitis and microscopic polyangiitis; Jan Henrik Schirmer et.al. RMD Open 2023.
- EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update; Bernhard Hellmich et.al. Ann Rheum Dis 2024.
- 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Sharon A. Chung et.al.Arthritis Care & Research August 2021.
- ANCA-associated vasculitis; A. Richard Kitching et.al. Nat Rev Dis Primers(2020).
- ANCA-Associated Vasculitis: Core Curriculum 2020; Duvuru Geetha et.al, Am J Kidney Dis. (2020).
- Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Brix SR et. al. , Kidney Int. 2018.
- Diagnosis and management of ANCA-associated vasculitis; Andreas Kronbichler et.al. Lancet 2024.
- Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations , Marta Casal Moura et.al. Nephrol Dial Transplant, 2023.
- Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies.
- Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice ; Baptiste Chevet et.al. Rheumatology, 2023.
- Treatment Updates in Antineutrophil Cytoplasmic Autoantibodies (ANCA) Vasculitis , Koyal Jain et.al. KIDNEY360.
- ANCA-associated vasculitis—treatment standard; Aglaia Chalkia et.al. Nephrol Dial Transplant,2024.
- Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline; Linan Zeng et.al. BMJ 2022.
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
- Avacopan for the Treatment of ANCA-Associated Vasculitis David R.W.
- Avacopan in ANCA-associated Vasculitis in a real- world setting, Zimmermann J et. al, Kidney International Reports (2024).
- Avacopan in ANCA-associated Vasculitis in a real- world setting, Zimmermann J et. al, Kidney International Reports (2024).
Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?
- Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives.
Evolution of Therapy for ANCA-Associated Vasculitis with Kidney Involvement.
- Infectious triggers for vasculitis; Mirjan M. van Timmeren et.al. Curr Opin Rheumatol 2014.
- ANCA‑Associated Vasculitis: Practical Issues in Management. Roper T et.al.Indian J Nephrol 2024.
- ANCA‑Associated Vasculitis with Systemic Thrombotic Microangiopathy: A Review of Literature. Shukla S et al.; Indian J Nephrol. 2024.
- The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome; Matteo Stella et.al. Clinical Kidney Journal,2024.
- Immunopathogenesis of ANCA-Associated Vasculitis; Andreas Kronbichler et.al., Int. J. Mol. Sci. 2020.
Section Contributors
Dr. Hardik patel
Dr. soumya
Dr. Nikita pawar
Dr. manish rathi
Dr. nikhil bhasin
